- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03286686
Sensori-motor and Perceptual Functions of the PPC. (PPCfonctions)
Sensori-motor and Perceptual Functions of the Posterior Parietal Cortex (PPC) in Patients With Optic Ataxia (AO) and Healthy Subjects.
To produce hand's movement directed towards a target, the investigator must combine several sensory information, such as vision or proprioception. The posterior parietal cortex (PPC) is a region of the cortex involved in this multisensory integration. A lesion of the PPC cause a visuo-motor trouble called optic ataxia but these patients also have perceptual troubles.
The aim of the study is to understand the different functions of the PPC and especially how the processes of spatial coding of the sensory information influences perception and motor planning.
In this study, the investigator want to explore the sensory motor and the perceptual performance of patients with optic ataxia compared with healthy subjects, using 6 behavioral tests.
Objectify the consequences of PPC impairment (visual-motor and perceptual consequences) on patients' quality of life and autonomy.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Laure Pisella, PhD
- Phone Number: +33 4 72 91 34 05
- Email: laure.pisella@inserm.fr
Study Locations
-
-
-
Bron, France, 69500
- Recruiting
- U1028 INSERM - CNRS UMR 5292 Equipe ImpAct
-
Contact:
- Laure Pisella, PhD
- Phone Number: +33 4 72 91 34 05
- Email: laure.pisella@inserm.fr
-
Principal Investigator:
- Laure Pisella, PhD
-
Sub-Investigator:
- Sophie JACQUIN-COURTOIS, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
All patients and healthy subjects:
- male and female, age from 18 to 75 years included
- normal vision or corrected vision
- covered by social security
- signed written informed consent
Patients:
- neurological injury in posterior parietal cortex supported by a cerebral MRI
- present optic ataxia symptoms Healthy subjects
- no known neurological injury
Exclusion Criteria:
- unable to comply with the tasks (neurological, psychiatric, sensory or motor troubles)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experience 1
|
In the experiences 1 and 2, the participant needs to point different visual targets (LED) in the dark.
|
|
Experimental: Experience 2
|
In the experiences 1 and 2, the participant needs to point different visual targets (LED) in the dark.
|
|
Experimental: Experience 3
|
In the experience 3, a tactile stimulation is applied to the middle finger of the 2 hands.
The participant needs to indicate into a microphone when he feels the stimulation.
|
|
Experimental: Experience 4
|
Target dots or visual images are presented on a computer screen.
The participant is required to point to the targets or to react as soon as possible by pressing a response button when they are detected.
|
|
Experimental: Experience 5
|
Target dots or visual images are presented on a computer screen.
The participant is required to point to the targets or to react as soon as possible by pressing a response button when they are detected.
|
|
Experimental: Experience 6
|
Target dots or visual images are presented on a computer screen.
The participant is required to point to the targets or to react as soon as possible by pressing a response button when they are detected.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
response error - number of pointing error
Time Frame: Day 0 after each stimulation
|
Day 0 after each stimulation
|
|
response error -measure of reaction times
Time Frame: Day 0 after each stimulation
|
Day 0 after each stimulation
|
|
response error - percentage of right responses
Time Frame: Day 0 after each stimulation
|
Day 0 after each stimulation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Laure PISELLA, PhD, INSERM U1028 - Impact - CRNL
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL17_0341
- 2017-A02562-51 (Other Identifier: ID-RCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
National and Kapodistrian University of AthensCompletedHealthy Adults | Healthy Volunteers OnlyGreece
Clinical Trials on point targets
-
Diskapi Teaching and Research HospitalCompleted
-
Indiana UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPregnancy, High Risk | Overweight and Obesity | Gestational DiabetesUnited States
-
University of British ColumbiaWithdrawn
-
University of OklahomaCompleted
-
University of LiegeHasselt University; RWTH Aachen University; Maastricht UniversityNot yet recruitingHealthyBelgium, Netherlands, Germany
-
Vanderbilt University Medical CenterSarah Osmundson, MD, MS; Alex Phelps, MD; Julia Phillippi, PhD, CNM; Soha Patel... and other collaboratorsCompletedHypertension, Pregnancy-Induced | Postpartum Preeclampsia | Hypertension; MaternalUnited States
-
Ohio State UniversityOhio Lions Eye Research FundRecruitingTraumatic Brain Injury (TBI) PatientsUnited States
-
University of Southern CaliforniaRecruitingDiabetes Mellitus, Type 2 | Diabetes, Gestational | Diabetes Mellitus in PregnancyUnited States
-
Federal State Budgetary Institution, V. A. Almazov...CompletedGestational Diabetes MellitusRussia
-
Stanford UniversityVA Palo Alto Health Care SystemEnrolling by invitationHeart FailureUnited States